Chronic Cocaine Effects in Retinal Metabolism and Electrophysiology: Treatment with Topiramate

REFERENCES

• United Nations. Office on Drugs and Crime. 2007 World Drug Report-Global illicit drug trends. Available at: http://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html [last accessed 17 Feb 2012]
   Google Scholar
• The European Monitoring Centre for Drugs and Drug Addiction. 2007 Annual report on the state of the drugs problem in Europe. Available at: http://www.emcdda.europa.eu/html.cfm/index419EN.html [last accessed 17 Feb 2012]
   Google Scholar
• Delegación del Gobierno para el Plan Nacional sobre Drogas. Observatorio español sobre drogas. Informe 2004. Ministerio de Sanidad y Consumo. Available at: http://www.pnsd.msc.es/Categoria2/publica/pdf/oed-2004.pdf [last accessed 17 Feb 2012]
   Google Scholar
• Dackis CA, Gold MS. Psychopharmacology of cocaine. Psychiatr Ann 1988;18:528–530
   Google Scholar
• Giannini AJ, Folts DJ, Feather JN, Sullivan BS. Bromocriptine and amantadine in cocaine detoxification. Psychiatr Res 1989;29:11–16
   PubMed Web of Science ®Google Scholar
• Washton AM, Gold MS. Cocaine: a clinician’s handbook. New York: Guilford Press; 1987
   Google Scholar
• Block SS, Moore BD, Scharre JE. Visual anomalies in young children exposed to cocaine. Optom Vis Sci 1997;74: 28–36
   Google Scholar
• Good WV, Ferriero DM, Golabi M, Kobori JA. Abnormalities of the visual system in infants exposed to cocaine. Ophthalmology 1992;99:341–346
   Google Scholar
• Méndez-Armenta M, Barroso-Moguel R, Villeda-Hernández J, Romero-Díaz V, Ríos C. Retinal lesions in rat fetuses prenatally exposed to cocaine. Neurotoxicol Teratol 1997;19:199–203
   Google Scholar
• Silva-Araújo A, Abreu-Dias P, Salgado-Borges J, Tavares M. Retinal changes induced by neonatal cocaine exposure in the rat. Graefes Arch Clin Exp Ophthalmol 1994;232:162–166
   Google Scholar
• Silva-Araújo A, Tavares MA. Development of the eye after gestational exposure to cocaine. Vascular disruption in the retina of rats and humans. Ann N Y Acad Sci 1996;801:274–288
   Google Scholar
• Silva-Araújo A, Tavares MA, Patacao MH, Carolino RM. Retinal hemorrhages associated with in utero exposure to cocaine. Experimental and clinical findings. Retina 1996;16:411–418
   Google Scholar
• Silva-Araújo A, Abreu-Dias P, Silva MC, Tavares MA. Effects of prenatal cocaine exposure in the photoreceptor cells of the rat retina. Mol Neurobiol 1995;11:77–86
   Google Scholar
• Silva-Araújo A, Salgado-Borges J, Cardoso V, Silva MC, Castro-Correia J, Tavares MA. Changes in the retinal ganglion cell layer and optic nerve of rats exposed neonatally to cocaine. Exp Eye Res 1993;56:199–206
   Google Scholar
• Leung IY, Lai S, Ren S, Kempen J, Klein R, Tso MO, Lai HC. Early retinal vascular abnormalities in African-American cocaine users. Am J Ophthalmol 2008;146:612–619
   Google Scholar
• Sleiman I, Mangili R, Semeraro F, Mazzilli S, Spandrio S, Balestrieri GP. Cocaine-associated retinal vascular occlusion: report of two cases. Am J Med 1994;97:198–199
   PubMed Web of Science ®Google Scholar
• Ascaso FJ, Cruz N, Del Buey MA, Cristóbal JA. An unusual case of cocaine-induced maculopathy. Eur J Ophthalmol 2009;19:880–882
   Web of Science ®Google Scholar
• Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry 1996;168:507–511
   PubMed Web of Science ®Google Scholar
• Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry 1997;54:153–156
   PubMed Web of Science ®Google Scholar
• Smelson DA, Roy M, Roy A, Santana S. Electroretinogram in withdrawn cocaine-dependent subjects. Relationship to cue-elicited craving. Br J Psychiatry 1998;172:537–539
   PubMed Web of Science ®Google Scholar
• Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse 2001;27:391–397
   PubMed Web of Science ®Google Scholar
• Uys JD, Knackstedt L, Hurt P, Tew KD, Manevich Y, Hutchens S, et al. Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity. Neuropsychopharmacology 2011;36:2551–2560
   Google Scholar
• Muriach M, López-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, Romero FJ. Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 2010;114:675–684
   PubMed Web of Science ®Google Scholar
• Lee CT, Chen J, Hayashi T, Tsai SY, Sanchez JF, Errico SL, et al. A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med 2008;10;5:e117
   Google Scholar
• Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it. Ann Neurol 1992;32:804–812
   PubMed Web of Science ®Google Scholar
• Smeets WJ, González A. Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach. Brain Res Brain Res Rev 2000;33:308–379
   Google Scholar
• Kalivas PW, O’Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008;33:166–180
   PubMed Web of Science ®Google Scholar
• Johnson J, Tian N, Caywood MS, Reimer RJ, Edwards RH, Copenhagen DR. Vesicular neurotransmitter transporter expression in developing postnatal rodent retina: GABA and glycine precede glutamate. J Neurosci 2003;23:518–529
   Google Scholar
• Privitera MD. Topiramate: a new antiepileptic drug. Ann Pharmacother 1997;31:1164–1173
   PubMed Web of Science ®Google Scholar
• Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 2005;59:961–968
   PubMed Web of Science ®Google Scholar
• Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry 2003;64:1449–1454
   PubMed Web of Science ®Google Scholar
• Ioannides-Demos LL, Pronietto J, McNeil JJ. Pharmacotherapy for obesity. Drugs 2005;65:1391–1418
   PubMed Web of Science ®Google Scholar
• Dhuna A, Pascual-Leone A, Langendorf F, Anderson DC. Epileptogenic properties of cocaine in humans. Neurotoxicology 1991;12:621–626
   PubMed Web of Science ®Google Scholar
• Rubio G, Ponce G, Jiménez-Arriero MA, Palomo T, Manzanares J, Ferre F. Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychiatry 2004;37:37–40
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003;361:1677–1685
   PubMed Web of Science ®Google Scholar
• Zullino DF, Cottier AC, Besson J. Topiramate in opiate withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1221–1223
   PubMed Web of Science ®Google Scholar
• Baltieri DA, Daró FR, Ribeiro PL, Andrade AG. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. Drug Alcohol Depend 2009;105:33–41
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Hampa AD. Topiramate prevents ecstasy consumption: a case report. Fundam Clin Pharmacol 2005;19:601–602
   Google Scholar
• Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, et al. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol 2008;11:425–438
   PubMed Web of Science ®Google Scholar
• Uys JD, LaLumiere RT. Glutamate: the new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord Drug Targets 2008;7:482–491
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Mu P, Moyer JT, Wolf JA, Quock RM, Davies NM, et al. Homeostatic synapse-driven membrane plasticity in nucleus accumbens neurons. J Neurosci 2009;29:5820–5831
   PubMed Web of Science ®Google Scholar
• Schroeder JA, McCafferty MR, Unterwald EM. Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. Synapse 2009;63:863–870
   Google Scholar
• Rigoulot MA, Boehrer A, Nehlig A. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS. Epilepsia 2003;44:14–19
   PubMedGoogle Scholar
• Farook JM, Morrell DJ, Lewis B, Littleton JM, Barron S. Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice. Alcohol Alcohol 2007;42:296–300
   PubMed Web of Science ®Google Scholar
• Richard MJ, Guiraud P, Meo J, Favier A. High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a comercially available reagent. J Chromatogr 1992;77:9–18
   Google Scholar
• Romero MJ, Bosch-Morell F, Romero B, Rodrigo JM, Serra MA, Romero FJ. Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biol Med 1998;25:993–997
   PubMed Web of Science ®Google Scholar
• Lawrence RA, Parkhill LK, Burk RF. Hepatic cytosolic non-selenium dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J Nutr 1978;108:981–987
   PubMed Web of Science ®Google Scholar
• Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. Highperformance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 1980;106:55–62
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall JR. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275
   PubMed Web of Science ®Google Scholar
• Numa R, Kohen R, Poltyrev T, Yaka R. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 2008;155:649–658
   PubMed Web of Science ®Google Scholar
• Numa R, Baron M, Kohen R, Yaka R. Tempol attenuates cocaine-induced death of PC12 cells through decreased oxidative damage. Eur J Pharmacol 2011;650:157–162
   Google Scholar
• Yoles E, Friedmann I, Barouch R, Shani Y, Schwartz M. Self-Protective mechanism awakened by glutamate in retinal ganglion cells. J Neurotrauma 2001;18:339–349
   Google Scholar
• Karler R, Calder LD, Thai LH, Bedingfield JB. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res 1994;658:8–14
   Google Scholar
• Rockhold RW, Oden G, Ho IK, Andrew M, Farley JM. Glutamate receptor antagonists block cocaine-induced convulsions and death. Brain Res Bull 1991;27:721–723
   PubMedGoogle Scholar
• Jimenez-Rivera CA, Waterhouse BD. Effects of systemically and locally applied cocaine on cerebrocortical neuron responsiveness to afferent synaptic inputs and glutamate. Brain Res 1991;546:287–296
   Google Scholar
• Moreno MC, Sande P, Marcos HA, de Zavalía N, Keller Sarmiento MI, Rosenstein RE. Effect of glaucoma on the retinal glutamate/glutamine cycle activity. FASEB J 2005;19:1161–1162
   PubMed Web of Science ®Google Scholar
• Ambati J, Chalam KV, Chawla DK, D’Angio CT, Guillet EG, Rose SJ, et al. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997;115:1161–1166
   PubMed Web of Science ®Google Scholar
• Greenberger LM, Besharse JC. Stimulation of photoreceptor disc shedding and pigment epithelial phagocytosis by glutamate, aspartate, and other amino acids. J Comp Neurol 1985;239:361–372
   PubMed Web of Science ®Google Scholar
• Delyfer MN, Forster V, Neveux N, Picaud S, Léveillard T, Sahel JA. Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina. Mol Vis 2005;11:688–696
   Google Scholar
• Robson JG, Frishman LJ. Dissecting the dark-adapted electroretinogram. Doc Ophthalmol 1998;95:187–215
   Google Scholar
• Kanda T, Kurokawa M, Tamura S, Nakamura J, Ishii A, Kuwana Y, et al. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER). Life Sci 1996;59:1607–1616
   PubMed Web of Science ®Google Scholar
• Yoneda S, Tanaka E, Goto W, Ota T, Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res 2003;967:257–266
   PubMed Web of Science ®Google Scholar
• Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, Akbari M. Topiramate and the vision: a systematic review. Clin Ophthalmol 2012;6:117–131
   PubMedGoogle Scholar
• Ozturk BT, Genc E, Tokgoz M, Kerimoglu H, Genc BO. Ocular changes associated with topiramate. Curr Eye Res 2011;36:47–52
   PubMed Web of Science ®Google Scholar